Healthcare Global Enterprises Ltd. (HCG) fundamentals
Healthcare Global Enterprises Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as HCG (ISIN INE075I01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Healthcare Global Enterprises Ltd. does
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company offers cancer care, fertility treatment, advanced screening and diagnostic services, and tertiary care. It operates a cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company provides fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Triesta brand offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company operates a comprehensive cancer care center in Indore, Madhya Pradesh. It is also engaged in the radiation business in Indore, Madhya Pradesh. Its multispecialty hospitals deliver tertiary care for cardiac, bone and joint, brain, and spine.
Valuation and market data
| Last close | ₹693.90 |
|---|---|
| Market capitalisation | ₹10,622 crore |
| Enterprise value | ₹11,765 crore |
| P/E (TTM) | 0.00 |
| Price to book | 10.73 |
| Price to sales (TTM) | 4.00 |
| Book value per share | ₹64.68 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Wed Mar 30 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,395 crore | ₹10 crore | ₹15 crore | 0.00 |
| Mar 2025 | ₹1,315 crore | ₹20 crore | ₹4 crore | 0.25 |
| Mar 2024 | ₹1,116 crore | ₹55 crore | ₹34 crore | 2.44 |
| Mar 2023 | ₹1,016 crore | ₹58 crore | ₹40 crore | 2.89 |
| Mar 2022 | ₹862 crore | ₹81 crore | ₹38 crore | 2.95 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 64.2% |
|---|---|
| Foreign institutions (FII) | 2.7% |
| Mutual funds | 15.4% |
| Other domestic institutions | 3.8% |
| Retail and others | 13.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.